| Year |
Citation |
Score |
| 2017 |
Yasui T, Yamamoto T, Sakai N, Asano K, Takai T, Yoshitomi Y, Davis M, Takagi T, Sakamoto K, Sogabe S, Kamada Y, Lane W, Snell G, Iwata M, Goto M, et al. Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design. Bioorganic & Medicinal Chemistry. PMID 28760529 DOI: 10.1016/J.Bmc.2017.07.037 |
0.439 |
|
| 2012 |
Davis MR, Singh EK, Wahyudi H, Alexander LD, Kunicki JB, Nazarova LA, Fairweather KA, Giltrap AM, Jolliffe KA, McAlpine SR. Synthesis of sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds. Tetrahedron. 68: 1029-1051. PMID 22287031 DOI: 10.1016/J.Tet.2011.11.089 |
0.719 |
|
| 2010 |
Sellers RP, Alexander LD, Johnson VA, Lin CC, Savage J, Corral R, Moss J, Slugocki TS, Singh EK, Davis MR, Ravula S, Spicer JE, Oelrich JL, Thornquist A, Pan CM, et al. Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives. Bioorganic & Medicinal Chemistry. 18: 6822-56. PMID 20708938 DOI: 10.1016/J.Bmc.2010.07.042 |
0.592 |
|
| 2009 |
Alexander LD, Sellers RP, Davis MR, Ardi VC, Johnson VA, Vasko RC, McAlpine SR. Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action. Journal of Medicinal Chemistry. 52: 7927-30. PMID 20014866 DOI: 10.1021/Jm901566C |
0.737 |
|
| 2009 |
Pan PS, Vasko RC, Lapera SA, Johnson VA, Sellers RP, Lin CC, Pan CM, Davis MR, Ardi VC, McAlpine SR. A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines. Bioorganic & Medicinal Chemistry. 17: 5806-25. PMID 19643615 DOI: 10.1016/J.Bmc.2009.07.017 |
0.618 |
|
| 2008 |
Davis MR, Styers TJ, Rodriguez RA, Pan PS, Vasko RC, McAlpine SR. Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles. Organic Letters. 10: 177-80. PMID 18095697 DOI: 10.1021/Ol702403R |
0.776 |
|
| Show low-probability matches. |